Literature DB >> 19394301

Global regulators orchestrate group II intron retromobility.

Colin J Coros1, Carol Lyn Piazza, Venkata R Chalamcharla, Dorie Smith, Marlene Belfort.   

Abstract

Group II introns are hypothesized to share common ancestry with both nuclear spliceosomal introns and retrotransposons, which collectively occupy the majority of genome space in higher eukaryotes. These phylogenetically diverse introns are mobile retroelements that move through an RNA intermediate. Disruption of Escherichia coli genes encoding enzymes that catalyze synthesis of global regulators cAMP and ppGpp inhibits group II intron retromobility. These small molecules program genetic transitions between nutrient excess and starvation. Accordingly, we demonstrated that glucose depletion of wild-type cells and cAMP supplementation of mutants stimulated retromobility. Likewise, amino acid starvation, which induces the alarmone ppGpp, activated retromobility. In both cases, retrotransposition to ectopic sites was favored over retrohoming. Interestingly, these stimulatory effects are mediated at the level of the DNA target, rather than of expression of the retroelement. Thereby, during metabolic stress, cAMP and ppGpp control group II intron movement in concert with the cell's global genetic circuitry, stimulating genetic diversity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19394301      PMCID: PMC2690983          DOI: 10.1016/j.molcel.2009.03.014

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  30 in total

1.  Retrotransposition of the Ll.LtrB group II intron proceeds predominantly via reverse splicing into DNA targets.

Authors:  Kenji Ichiyanagi; Arthur Beauregard; Stacey Lawrence; Dorie Smith; Benoit Cousineau; Marlene Belfort
Journal:  Mol Microbiol       Date:  2002-12       Impact factor: 3.501

2.  The RmInt1 group II intron has two different retrohoming pathways for mobility using predominantly the nascent lagging strand at DNA replication forks for priming.

Authors:  Francisco Martínez-Abarca; Antonio Barrientos-Durán; Manuel Fernández-López; Nicolás Toro
Journal:  Nucleic Acids Res       Date:  2004-05-20       Impact factor: 16.971

3.  Group II intron mobility using nascent strands at DNA replication forks to prime reverse transcription.

Authors:  Jin Zhong; Alan M Lambowitz
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

4.  Homing of a group II intron from Lactococcus lactis subsp. lactis ML3.

Authors:  D A Mills; D A Manias; L L McKay; G M Dunny
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

5.  Characterization of the relA1 mutation and a comparison of relA1 with new relA null alleles in Escherichia coli.

Authors:  S Metzger; G Schreiber; E Aizenman; M Cashel; G Glaser
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

6.  Stringent control of protein synthesis in E. coli.

Authors:  T Laffler; J A Gallant
Journal:  Cell       Date:  1974-09       Impact factor: 41.582

Review 7.  Transcriptional regulation by cAMP and its receptor protein.

Authors:  A Kolb; S Busby; H Buc; S Garges; S Adhya
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

8.  A bacterial group II intron encoding reverse transcriptase, maturase, and DNA endonuclease activities: biochemical demonstration of maturase activity and insertion of new genetic information within the intron.

Authors:  M Matsuura; R Saldanha; H Ma; H Wank; J Yang; G Mohr; S Cavanagh; G M Dunny; M Belfort; A M Lambowitz
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

9.  Control of spoT-dependent ppGpp synthesis and degradation in Escherichia coli.

Authors:  K D Murray; H Bremer
Journal:  J Mol Biol       Date:  1996-05-31       Impact factor: 5.469

10.  Allosteric changes in the cAMP receptor protein of Escherichia coli: hinge reorientation.

Authors:  J Kim; S Adhya; S Garges
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more
  27 in total

Review 1.  The tertiary structure of group II introns: implications for biological function and evolution.

Authors:  Anna Marie Pyle
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-06       Impact factor: 8.250

Review 2.  Group II introns: mobile ribozymes that invade DNA.

Authors:  Alan M Lambowitz; Steven Zimmerly
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

3.  Scientific serendipity initiates an intron odyssey.

Authors:  Marlene Belfort
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

4.  DNA cleavage and reverse splicing of ribonucleoprotein particles reconstituted in vitro with linear RmInt1 RNA.

Authors:  María Dolores Molina-Sánchez; Nicolás Toro
Journal:  RNA Biol       Date:  2019-04-14       Impact factor: 4.652

Review 5.  Group II Intron RNPs and Reverse Transcriptases: From Retroelements to Research Tools.

Authors:  Marlene Belfort; Alan M Lambowitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

6.  What limits the efficiency of double-strand break-dependent stress-induced mutation in Escherichia coli?

Authors:  Chandan Shee; Rebecca Ponder; Janet L Gibson; Susan M Rosenberg
Journal:  J Mol Microbiol Biotechnol       Date:  2012-01-13

7.  A group II intron-encoded protein interacts with the cellular replicative machinery through the β-sliding clamp.

Authors:  Fernando M García-Rodríguez; José L Neira; Marco Marcia; María D Molina-Sánchez; Nicolás Toro
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

Review 8.  Mobile self-splicing introns and inteins as environmental sensors.

Authors:  Marlene Belfort
Journal:  Curr Opin Microbiol       Date:  2017-05-05       Impact factor: 7.934

Review 9.  Mobile Group II Introns as Ancestral Eukaryotic Elements.

Authors:  Olga Novikova; Marlene Belfort
Journal:  Trends Genet       Date:  2017-08-14       Impact factor: 11.639

10.  Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance.

Authors:  Devon M Fitzgerald; P J Hastings; Susan M Rosenberg
Journal:  Annu Rev Cancer Biol       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.